ライフサイエンスコーパス: viral disease

1 et for therapeutic intervention against this viral disease.

2 eneficial role in the outcome of respiratory viral disease.

3 medical intervention for preventing epidemic viral disease.

4 gue, the most important mosquito-transmitted viral disease.

5 shown efficacy in experimental models of CNS viral disease.

6 ceptible mice from mousepox, an acute lethal viral disease.

7 V-1 to -4) cause the most important emerging viral disease.

8 can protect older individuals against severe viral disease.

9 NASH complicates hepatotropic viral disease.

10 potential therapeutics against this emerging viral disease.

11 Barr virus viremia (23% vs. 31%) or clinical viral disease.

12 t also powerfully shapes the presentation of viral disease.

13 ogen invasion and leading to protection from viral disease.

14 information to protect from, or treat, human viral disease.

15 serious bacterial infections concurrent with viral disease.

16 ines and antiviral therapies for this common viral disease.

17 n which apoE may determine the severity of a viral disease.

18 resulting plants did not suffer from severe viral disease.

19 menting roles in the resolution of influenza viral disease.

20 ssociated pathway of apoptotic cell death in viral disease.

21 c spread of the virus and development of the viral disease.

22 deficiency that results in fatal and severe viral disease.

23 to thrive and were extremely susceptible to viral disease.

24 burden, is the most important mosquito-borne viral disease.

25 d contributes to tissue injury, exacerbating viral disease.

26 disease virus (FMDV) is a highly contagious viral disease.

27 manage both aphids and aphid-vectored plant viral disease.

28 and evaluate antibodies against an emerging viral disease.

29 s, and this event plays an important role in viral disease.

30 ct cell types to orchestrate resistance to a viral disease.

31 nsplantation contribute to this high rate of viral disease.

32 a majority of infant hospitalizations due to viral disease.

33 is nonhuman primate model for AIDS and other viral diseases.

34 e immune system effectively protects us from viral diseases.

35 oxic T cells for immunotherapy of cancer and viral diseases.

36 tep towards the prevention and cure of human viral diseases.

37 the maintenance and transmission of zoonotic viral diseases.

38 host immune responses in many bacterial and viral diseases.

39 hepatitis B virus infection or other chronic viral diseases.

40 loping a fully informed approach to tackling viral diseases.

41 ectrum of pathologies, including cancers and viral diseases.

42 th the goal of enhancing their resistance to viral diseases.

43 y in 2 siblings presenting mycobacterial and viral diseases.

44 r tumorigenesis, development, metabolism and viral diseases.

45 stricts the number of effective vaccines for viral diseases.

46 may be a novel therapeutic target in chronic viral diseases.

47 ity contributes to neoplastic, metabolic and viral diseases.

48 rtain how immunity protects against systemic viral diseases.

49 ation to facilitate the management of tomato viral diseases.

50 on events are often associated with emergent viral diseases.

51 iruses are the second leading cause of human viral diseases.

52 t 80 years to control agricultural losses to viral diseases.

53 approach could be useful in the treatment of viral diseases.

54 ment with ribavirin and IFN in other chronic viral diseases.

55 ization for the treatment of HIV-1 and other viral diseases.

56 de drugs used in the treatment of cancer and viral diseases.

57 drugs to combat various forms of cancer and viral diseases.

58 te the prediction and prevention of emerging viral diseases.

59 iral hepatitis and other chronic progressive viral diseases.

60 f infections, they may be applicable to many viral diseases.

61 e autoimmune events in certain bacterial and viral diseases.

62 phylactic vaccine vectors to combat emerging viral diseases.

63 to enhanced susceptibility or resistance to viral diseases.

64 ions, and facilitates management of emerging viral diseases.

65 rkable successes in the control of childhood viral diseases.

66 lopment of novel antiviral therapies against viral diseases.

67 aegypti mosquitoes are important vectors of viral diseases.

68 hat may represent a new mechanism to prevent viral diseases.

69 gnificant promise for reducing the burden of viral diseases.

70 cytokines that are instrumental in combating viral diseases.

71 mportant foodborne bacterial, protozoal, and viral diseases.

72 SG15 deficiency but without unusually severe viral diseases.

73 c vaccination in the treatment of persistent viral diseases.

74 ng many that are involved in pathogenesis of viral diseases.

75 demand to develop new strategies to control viral diseases.

76 ritical roles in the pathogenesis of chronic viral diseases.

77 lement large-scale molecular surveillance of viral diseases.

78 erefore a cure is lacking for many prevalent viral diseases.

79 lies and are known causative agents of fatal viral diseases.

80 ISG15 deficiency and mycobacterial, but not viral, diseases.

81 A total of 70.5% of the children had viral disease, 22.0% had bacterial disease, and 10.9% ha

82 d individuals and correlated with markers of viral disease activity (viral load, CD8+ T cells, and CD

83 o that therapeutic interventions that reduce viral disease activity may not predictably reduce arteri

84 ally identified as a mediator of synergistic viral disease, acts to suppress the establishment of bot

85 d-mouth disease (FMD) is a highly contagious viral disease affecting biungulate species.

86 f cassava brown streak disease, an important viral disease affecting one of Africa's staple crops.

87 swine fever (CSF), an economically important viral disease affecting the pig industry in many countri

88 T lymphocytes (CTLs) can effectively prevent viral disease after conventional stem cell transplantati

89 Recurrent viral disease after transplant remains a significant cha

90 virus-specific immunity to prevent or treat viral diseases after HSCT.

91 on the prevention and management of chronic viral diseases among injection drug users.

92 eloped to explore the population dynamics of viral diseases among wildlife.

93 Anti-HMGB1 mitigated both early-life viral disease and asthma-like features, highlighting HMG

94 on, yet mice had considerable morbidity from viral disease and bacterial superinfection.

95 eting the hijacking of N-glycan synthesis in viral disease and cancer.

96 elopment of immunotherapy protocols to treat viral disease and cancer.

97 (ProTide) therapies used in the treatment of viral disease and cancer.

98 outcomes of liver transplantation, recurrent viral disease and malignancy remain major challenges.

99 Dengue is the most frequent hemorrhagic viral disease and re-emergent infection in the world.

100 subjects on suppressive HAART with residual viral disease and reservoirs can now be stratified.

101 ogenic host response in the setting of acute viral disease and that abrogation of this response ameli

102 definable risk of the transmission of severe viral disease and the induction of immunological reactio

103 nt of peptide-based vaccines against chronic viral diseases and cancer.

104 e been implicated in the outcome of a number viral diseases and cancers.

105 develop cassava with enhanced resistance to viral diseases and insects pests, improved nutritional c

106 as therapy for the treatment of a variety of viral diseases and malignancies including multiple myelo

107 infection is the most common mosquito-borne viral disease, and it can cause life-threatening dengue

108 Dengue is the most important arthropod-borne viral disease, and it is a major public health problem i

109 rcial animal production, with an emphasis on viral diseases, and discuss the existing hurdles to its

110 cribing the transmission dynamics of chronic viral diseases, and for evaluating control strategies di

111 for causing extensive crop damage, vectoring viral diseases, and permanently destabilizing IPM system

112 essfully developed as vaccines against other viral diseases, and safety concerns have recently been a

113 Mosquito-borne viral diseases are a major concern of global health and

114 neration of drug resistance in bacterial and viral diseases as well as cancers, and the development o

115 Measles is an acute viral disease associated both with immune suppression an

116 ic targets for the neoplastic, metabolic and viral diseases associated with JunD/AP-1 expression.

117 tant considerations for therapies of chronic viral diseases, autoimmune diseases, and cancers.

118 Aedes aegypti is a major vector of numerous viral diseases, because it requires a blood meal to faci

119 multidimensional effects of HLA molecules in viral disease become apparent.

120 t development, was advantageous during early viral disease but deleterious in later disease.

121 ponses appear to be beneficial during early, viral disease but detrimental in later disease when vira

122 de new tools for prophylaxis and therapy for viral diseases but also identify conserved epitopes that

123 es or vaccine candidates exist against these viral diseases, but all could potentially be improved if

124 killer (NK) cells confer resistance to many viral diseases, but in only a few instances the molecula

125 c T cells and indicates that T cell-mediated viral disease can occur even under conditions of immunos

126 emerging mosquito-borne zoonotic infectious viral disease caused by the RVF virus (RVFV) (Bunyavirid

127 concentrations of cadmium completely blocked viral disease caused by turnip vein clearing virus.

128 Dengue is the most common vector-borne viral disease, causing nearly 400 million infections yea

129 Dengue is an acute mosquito-transmitted viral disease characterised by fever, headache, muscle a

130 In addition to their function in viral disease, chemokines have been implicated in the pa

131 Treatment in most cases of bacterial and viral diseases consists of correcting fluid loss and ele

132 Infectious pancreatic necrosis (IPN) is a viral disease currently presenting a major problem in th

133 Viral diseases discussed include influenza, hepatitis B,

134 t of successful vaccine strategies for other viral diseases disproportionately affecting the elderly,

135 sical swine fever (CSF), a highly contagious viral disease endangering the pig industry in many count

136 Rift Valley fever (RVF) is a mosquito-borne viral disease endemic to Africa, characterized by high r

137 Congo hemorrhagic fever, a highly contagious viral disease endemic to more than 30 countries, has lim

138 We report 2 cases of Ebola viral disease (EVD) in pregnant women who survived, init

139 environments, with important implications in viral disease evolution.

140 ombocytopenia syndrome (SFTS) is an emerging viral disease for which there are currently no therapeut

141 d the ecological and evolutionary drivers of viral diseases from data on disease incidence as well as

142 Licensed vaccines against viral diseases generate antibodies that neutralize the i

143 in the pathogenesis of a highly lethal human viral disease, hantavirus pulmonary syndrome (HPS).

144 The design of vaccines against viral disease has evolved considerably over the past 50

145 ssemination and pathogenesis of a tick-borne viral disease has never been attempted before.

146 specificity for the identification of these viral diseases; however, the preparation of cell culture

147 e context of addressing a fictional emerging viral disease, I describe the process of discovery, from

148 information to facilitate the management of viral diseases.IMPORTANCE Tomato is an important source

149 to be the causative agent of a serious duck viral disease in Asia.

150 B, which may be of value to prevent or treat viral disease in CB transplant recipients.

151 and a prominent cause of insect-transmitted viral disease in Central and South America.

152 H7N9 avian influenza is an emerging viral disease in China caused by avian influenza A (H7N9

153 e an effective strategy for the treatment of viral disease in general and viral myocarditis in partic

154 ing adenoviremia and preventing disseminated viral disease in hematopoietic cell transplant (HCT) rec

155 Dengue is the most common mosquito-borne viral disease in human beings, and vector control has no

156 NV) is the most prevalent insect-transmitted viral disease in humans globally, and currently no speci

157 Dengue is the most prevalent mosquito-borne viral disease in humans, and the lack of early prognosti

158 ENV-4), is a highly prevalent mosquito-borne viral disease in humans.

159 Dengue is the most common mosquito-borne viral disease in humans.

160 herapeutic approaches to combat this painful viral disease in humans.

161 y within IFITM3 determines susceptibility to viral disease in humans.

162 Viral disease in Ifitm3-/- mice was accompanied by eleva

163 n reconstitute specific immunity and/or cure viral disease in immunocompromised post-BMT patients.

164 omegalovirus (HCMV) remains a major cause of viral disease in immunosuppressed transplant patients.

165 s system, some satellite RNAs also intensify viral disease in particular host plants.

166 The transmission of viral disease in the operating room is an evolving probl

167 Hepatitis C is the most prevalent bloodborne viral disease in the United States and the deadliest.

168 enza impressively reflects the paradigm of a viral disease in which continued evolution of the virus

169 potent immune responses and protect against viral diseases in animal models.

170 Viral diseases in aquaculture are challenging because th

171 evelopment of new strategies for controlling viral diseases in human populations and agroecosystems.

172 trable antiviral regimen against respiratory viral diseases in humans.

173 irus (HBV) represents one of the most common viral diseases in humans.

174 that we tested, consistent with the lack of viral diseases in these patients.

175 a unique approach for treatment that reduces viral diseases in vivo.

176 o economically important yield losses due to viral diseases, including cassava brown streak disease a

177 to be an effective means for preventing many viral diseases, including smallpox, polio, measles, mump

178 arch for novel therapeutic interventions for viral disease is a challenging pursuit, hallmarked by th

179 dely adopted tool, transforming the way that viral disease is researched, monitored, and treated.

180 However, viral disease is still a major factor limiting tomato pr

181 tigation of PD-1 pathway blockade in chronic viral disease is warranted.

182 Adenovirus infection, which is a waterborne viral disease, is one of the most prevelant causes of hu

183 case fatality rates (30 to 50%) of any acute viral disease known.

184 e of highly endemic parasitic, bacterial and viral diseases makes individuals and populations vulnera

185 matitis virus (VSV) are effective in several viral disease models.

186 to evaluate in cases of either bacterial or viral disease monitoring.

187 xplain the relatively mild susceptibility to viral disease observed in STAT3- and IL-21R-deficient su

188 no disease in the valG group but two serious viral diseases occurred in the placebo group (one CMV; o

189 the impact on the spread of a mosquito-borne viral disease of a strategy that releases adult male ins

190 ek's disease (MD) is a devastating oncogenic viral disease of chickens caused by Gallid herpesvirus 2

191 d-mouth disease (FMD) is a highly contagious viral disease of cloven-hoofed ungulates that can lead t

192 gical agent of a contagious and often lethal viral disease of domestic pigs that has significant econ

193 ease virus (FMDV) causes a highly contagious viral disease of even-toed ungulates and is one of the m

194 Dengue disease is a mosquito-borne viral disease of expanding geographical range and incide

195 leafroll is the most complex and intriguing viral disease of grapevine (Vitis spp.).

196 evalent and rapidly spreading mosquito-borne viral disease of human beings.

197 ), make it the most important mosquito-borne viral disease of humans (50 to 100 million infections/ye

198 Dengue is a vector-borne viral disease of humans that endemically circulates in m

199 1-4) cause the most prevalent mosquito-borne viral disease of humans worldwide.

200 e fever is the most frequent arthropod-borne viral disease of humans, with almost half of the world's

201 -4) cause the most important arthropod-borne viral disease of humans.

202 he agent of the most widespread vector-borne viral disease of humans.

203 the pathogenesis of bronchiolitis, a common viral disease of infancy, and a recent U.K. family study

204 Dengue is a systemic arthropod-borne viral disease of major global public health importance.

205 Rinderpest is an acute and highly contagious viral disease of ruminants, often resulting in greater t

206 ver (CSF) is a notifiable, highly contagious viral disease of swine which results in severe welfare a

207 urveillance for CCoV variants and intestinal viral diseases of global significance.

208 Synergistic viral diseases of higher plants are caused by the intera

209 Mosquitoes are vectors of parasitic and viral diseases of immense importance for public health.

210 in elucidating the underlying mechanisms of viral diseases of the CNS.

211 mphopenia, especially in the case of chronic viral diseases or cancer immunotherapy.

212 Viral diseases or diseases due to genetic lesions could

213 in which genomic data can help us understand viral disease outbreaks, we aim to provide a resource th

214 nalysis is a powerful tool for understanding viral disease outbreaks.

215 g trend, including a shift from parasitic to viral diseases over time.

216 Viral disease, particularly cytomegalovirus infection, r

217 amental requirement for our understanding of viral disease pathogenesis.

218 the first time in a wild vertebrate facing a viral disease possibly due to herpesvirus (i) whether ne

219 bitors has implications for the treatment of viral disease.Production of reactive oxygen species is a

220 found in the context of severe bacterial and viral disease, recurrent hepatopathy and encephalopathy,

221 e against human filovirus diseases and other viral diseases representing major public health threats.

222 an NKC may contain orthologues for the mouse viral disease resistance genes, Cmv1 and Rmp1.

223 ss HLA class supertype boundaries in a human viral disease setting.

224 grouping of HLA class I molecules in a human viral disease setting.

225 clinical trials of adoptive immunotherapy of viral diseases should facilitate the design of clinical

226 own to be protective in the setting of other viral diseases such as Ebola infections.

227 inical efficacy for the treatment of chronic viral diseases such as hepatitis B virus, human papillom

228 Simple models of therapy for viral diseases such as hepatitis C virus (HCV) or human

229 show great promise as vaccines against other viral diseases such as human immunodeficiency virus type

230 ell immunity is critical for protection from viral disease, such as that caused by the human immunode

231 Preclinical work in other viral diseases, such as dengue, has demonstrated the pot

232 While there is clear evidence that viral diseases, such as polio and rabies, affected ancie

233 al replication and protects against a lethal viral disease, suggesting an interaction between cellula

234 aged hosts are generally more susceptible to viral diseases than the young, specific dysfunctions of

235 Dengue is a mosquito-borne viral disease that afflicts millions of individuals worl

236 Zika, a mosquito-borne viral disease that emerged in South America in 2015, was

237 Smallpox is an eradicated viral disease that has re-emerged as a potential bioterr

238 esults suggest that HS binding may attenuate viral disease that is dependent on high-titer viremia; h

239 Valley fever (RVF) is a mosquito-transmitted viral disease that is endemic to Africa and that has the

240 outh disease (FMD) is one of the most feared viral diseases that can affect livestock.

241 ergence of several novel diseases, including viral diseases, that have caused serious problems for pr

242 Compared to the number of viral diseases, the number of available vaccines is mini

243 ge-dependent increase in susceptibility to a viral disease to a specific defect of NK cells, opening

244 ls that are resistant to PRRS, the costliest viral disease to ever face the swine industry.

245 Because of the threat of emerging wildlife viral diseases to global biodiversity, fundamental resea

246 IFNs are used as therapeutic agents to treat viral diseases, understanding their antiviral mechanisms

247 the potential exists to eradicate a chronic viral disease using combination therapies that contain o

248 ap, alterations in source-sink patterns, and viral diseases vectored by aphids, which are phloem-feed

249 ition plays any role in the emergence of new viral diseases via alterations in he genotype of an infe

250 sms of the innate resistance of bats against viral diseases, we might gain important insights into ho

251 confer protection against severe respiratory viral disease when humoral immunity is overcome.

252 e explicable in terms of the transmission of viral diseases which shows that (i) T is determined by t

253 he epigenetic therapies for cancer and other viral diseases, which may open a new venue to cure chron

254 Rift Valley fever (RVF) is a vector-borne viral disease widespread in Africa.

255 nderstanding of the role of SOCS proteins in viral diseases will be essential in our struggle to modu

256 Dengue is an acute febrile viral disease with >100 million infections occurring eac

257 Infectious pancreatic necrosis (IPN) is a viral disease with a significant negative impact on the

258 Avian pox is a viral disease with a wide host range.

259 n, and has implications for the treatment of viral disease with adoptively transferred CD8+ T cells.

260 n-Congo hemorrhagic fever (CCHF) is a severe viral disease with high fatality rate.

261 openia syndrome (SFTS) is a novel tick-borne viral disease with high mortality.

262 ely to better prepare for and respond to new viral diseases with a focus on new paradigms for vaccine

263 Monitoring the emergence and re-emergence of viral diseases with the goal of containing the spread of

264 tor (TCR) usage is relatively common in many viral diseases yet surprising in the context of the larg